Advanced BioCatalytics Closes Round of Financing Led by BP Ventures

Investment enables Advanced BioCatalytics to expand its manufacturing capacity and development of a new class of industrial Protein Surfactant Complex™ (PSC™)

Irvine, CA – July 12, 2016 – Advanced BioCatalytics Corporation (ABC), a company leading breakthroughs in surfactant synergy technologies, announced today it has closed an expansion round of investment led by BP Ventures. The funding will be used to build out ABC’s manufacturing capability to support the growing demand of its patented ultra-high performance Protein Surfactant Complex™ (PSC™) and allow for further development in oil and gas sector applications.

PSC™ is a biotechnology rooted in leveraging fundamental forces of nature by harnessing essential compounds to provide unique benefits. ABC currently offers its unique and patented product line under the Accell®, Accell Clean® and AccellGreen® trademarks.

“This financing underscores the potential of ABC’s patented technology to disrupt multi-billion dollar industries,” said Chris Harano, CEO and president of ABC. “We are ushering in an entirely new way to enhance performance of various chemical formulations as well as other microbiology metabolic processes which can be applied across multiple verticals from industrial, water treatment, marine and energy.”

“We’re seeing the emergence of the next age of surfactants,” said Harano, “and along with the support of our investors, partners and customers, we’re transforming the way micro-proteins can be designed to dramatically improve industrial surfactant performance at a scale and cost that is competitive with traditional methods. BP is the perfect partner to help ABC expand its offering and scale appropriately.”

Protein Surfactant Complex™, PSC™, Accell®, Accell Clean® and AccellGreen® are trademarks of Advanced BioCatalytics Corporation.


About Advanced BioCatalytics
Advanced BioCatalytics Corporation (ABC), founded in 1996, is focused on Industrial Biotechnology. ABC uses micro-proteins to enhance performance of various industrial chemical formulations as well as other microbiology metabolic processes. ABC’s technology acts synergistically with surfactants to bring costs down, allowing the use of surfactants in applications where they were previously uneconomical. ABC is manufacturing at scale today and post revenue selling into multiple markets including cleaners, industrial and agricultural wetting agents, wastewater treatment, environmental remediation and energy applications. To learn more, please visit http://www.abiocat.com/


About BP Ventures
BP Ventures identifies and makes strategic investments in private, high growth, game-changing technology companies, accelerating cutting edge innovations across the entire energy spectrum. The Investment portfolio is primarily focused on emerging technologies in oil and gas exploration and production and downstream conversion processes. BP Ventures also partners with entrepreneurial companies specializing in biotech, water, advanced materials, and digital technology. To learn more, please visit http://www.bp.com/en/global/corporate/technology/technology-strategy/venturing.html


Media inquiries contact
Catherine Mahoney
Advanced BioCatalytics Corporation
18010 Skypark Circle, #130, Irvine, CA 92614
Phone: (949) 442-0880
email: cmahoney@abiocat.com